Faculty and guest speakers staging

C = Program Chair  |  F = Faculty |  S = Session Chair


Inhye Ahn, MD
Dana-Farber Cancer Institute
Boston, Massachusetts, United States

Paolo Ghia, MD, PhD
Università Vita-Salute San Raffaele
Milano, Italy

Tadeusz Robak, MD, PhD
Medical University of Lodz
Lodz, Poland

Jennifer Brown, MD, PhD
Dana-Farber Cancer Institute
Boston, Massachusetts
United States

Michael Gillette, MD, PhD
Broad Institute of MIT and Harvard
Cambridge, Massachusetts
United States

Andrew Roberts, MBBS, PhD, FRACP FRCPA
Peter MacCallum Cancer Centre
and Royal Melbourne Hospital
Melbourne, Australia

Jan Burger, MD, PhD
The University of Texas MD
Anderson Cancer Center
Houston, Texas
United States

John Gribben, MD, DSc
Barts Cancer Institute
London, United Kingdom

Kerry Rogers, MD
The Ohio State University
Comprehensive Cancer Center
Columbus, Ohio
United States

John Burke, MD
Rocky Mountain Cancer Centers
Aurora, Colorado
United States

Romain Guièze, MD
The University of Texas MD Anderson
Cancer Center
Houston, Texas
United States

Richard Rosenquist, MD, PhD
Karolinska Institutet
Stockholm, Sweden

Clara Chamba, MD
Muhimbili University of Health and Allied Sciences
Tanzania, Africa

Michael Hallek, MD, PhD
University of Cologne
Cologne, Germany

Davide Rossi, MD, PhD
Oncology Institute of Southern Switzerland IOSI
Bellinzona, Switzerland

Carlos Sergio Chiattone, MD, MSc, PhD
Santa Casa Medical School
Sao Paulo, Brazil

Peter Hillmen,  MB ChB, PhD
St. James’s University Hospital
Leeds, United Kingdom

Lydia Scarfo, MD
Vita-Salute San Raffaele University
Milan, Italy

Nicholas Chiorazzi, MD
The Feinstein Institutes for Medical Research
Northwell Health
Manhasset, New York
United States

Arnon Kater, MD, PhD
Cancer Center Amsterdam
Amsterdam, Netherlands

Anna Schuh, MD, PhD
University of Oxford
Oxford, England
United Kingdom

Florence Cymbalista, MD, PhD
Avicenne Hospital
Bobigny, France

Thomas J. Kipps, MD, PhD
University of California San Diego
La Jolla, California
United States

John Seymour, MBBS, PhD
Peter MacCallum Cancer Centre
Melbourne, Australia

Matthew Davids, MD, MMSc
Dana-Farber Cancer Institute
Boston, Massachusetts
United States

Rosa Lapalombella, PhD
The Ohio State University
Comprehensive Cancer Center
Columbus, Ohio
United States

Eugen Tausch, MD
Ulm University
Ulm, Germany

Peter Dreger, MD
Heidelberg University Hospital
Heidelberg, Germany

Carol Moreno, PhD
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain

William Wierda, MD, PhD
The University of Texas MD
Anderson Cancer Center
Houston, Texas
United States

Dimitar Efremov, MD, PhD
International Centre for Genetic
Engineering and Biotechnology
Trieste, Italy

Javid Moslehi, MD
Vanderbilt University Medical Center
Nashville, Tennessee
United States

Adrian Wiestner, MD, PhD
National Heart, Lung, and Blood Institute
Bethesda, Maryland
United States

Barbara Eichhorst, MD
University of Cologne
Cologne, Germany

Carsten Niemann, MD, PhD
Copenhagen University Hospital
Copenhagen, Denmark

Jennifer Woyach, MD
The Ohio State University
Comprehensive Cancer Center
Columbus, Ohio
United States

Gianluca Gaidano, MD, PhD
University of Eastern Piedmont
Novara, Italy

Andrea Pepper, PhD
University of Sussex
Brighton and Sussex Medical School
Brighton, United Kingdom

Catherine J. Wu, MD
Dana-Farber Cancer Institute
Boston, Massachusetts
United States

Jordan Gauthier, MD, MSc
Fred Hutchinson Cancer Center
Seattle, Washington
United States

Alan Ramsay, PhD
King’s College
London, United Kingdom

Shenmiao Yang, MD

Peking University People’s Hospital
Peking University Institute of Hematology
Beijing, China

Guest Speakers

Deborah Sims
Henderson Media Group
CLL Patient Advocate
Victoria, Australia
Brian Koffman, MDCM (retired),
DCFP,
FCFP, DABFP, MSEd
Executive Vice President
Chief Medical Office
CLL Society
Olathe, Kansas
United States
Zack Pemberton-Whiteley
Chief Executive Officer
Leukaemia Care
Worcester, United Kingdom
Lorna Warwick
Chief Executive Officer
Lymphoma Coalition
Mississauga, Ontario
Canada